A pharmacogenetic method for prediction of the efficacy of methotrexate monotherapy in recent-onset arthritis

Details for Australian Patent Application No. 2007289426 (hide)

Owner Academisch Ziekenhuis h.o.d.n. LUMC

Inventors Guchelaar, Hendrik Jan; Huizinga, Tom Willem Johannes

Agent Spruson & Ferguson

Pub. Number AU-A-2007289426

PCT Pub. Number WO2008/026922

Priority 06119819.8 30.08.06 EP; 60/840,973 30.08.06 US

Filing date 28 August 2007

Wipo publication date 6 March 2008

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

9 April 2009 PCT application entered the National Phase

  PCT publication WO2008/026922 Priority application(s): WO2008/026922

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007289432-Repair of cartilage tissue using a matrix gel containing chondrocytes

2007289419-A pharmaceutical composition for the treatment of a fungal skin disorder and a method for the preparation thereof